Magnetic Resonance Imaging Role in Metastatic Liver Disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125 |
Resumo: | Abstract The objective of this study is to provide a comprehensive overview of the utilization of magnetic resonance imaging (MRI) in the identification, characterization, and monitoring of liver metastatic disease, in contrast to alternative imaging modalities, through a bibliographical review and illustrative examples from the author’s clinical practice. The advantages of MRI in this specific context will be explored, emphasizing the utility of hepatospecific contrast agents and the limitations associated with alternative imaging modalities. A comparative analysis of these methods shows that MRI is the most sensitive and specific modality, even more so when using hepatospecific contrast agents, proving to have cost-effectiveness benefits in patient management. It is the authors’ opinion that, provided the technique is available, oncological patient staging where hepatic metastatic disease is a concern should include an abdominal MRI, if possible, with hepatospecific contrast. |
id |
RCAP_a9e27cb23f1433417f19c12134046d09 |
---|---|
oai_identifier_str |
oai:scielo:S2184-06282024000200125 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Magnetic Resonance Imaging Role in Metastatic Liver DiseaseLiver/diagnostic imagingLiver Neoplasms/ diagnostic imagingMagnetic Resonance ImagingAbstract The objective of this study is to provide a comprehensive overview of the utilization of magnetic resonance imaging (MRI) in the identification, characterization, and monitoring of liver metastatic disease, in contrast to alternative imaging modalities, through a bibliographical review and illustrative examples from the author’s clinical practice. The advantages of MRI in this specific context will be explored, emphasizing the utility of hepatospecific contrast agents and the limitations associated with alternative imaging modalities. A comparative analysis of these methods shows that MRI is the most sensitive and specific modality, even more so when using hepatospecific contrast agents, proving to have cost-effectiveness benefits in patient management. It is the authors’ opinion that, provided the technique is available, oncological patient staging where hepatic metastatic disease is a concern should include an abdominal MRI, if possible, with hepatospecific contrast.Círculo Médico2024-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125Gazeta Médica v.11 n.2 2024reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125Santana,Tomás França deLaert,JoséManso,Nuno LupiLuersen,Gustavo FelipeMatos,António Pedroinfo:eu-repo/semantics/openAccess2024-11-21T23:00:53Zoai:scielo:S2184-06282024000200125Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-11-21T23:00:53Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Magnetic Resonance Imaging Role in Metastatic Liver Disease |
title |
Magnetic Resonance Imaging Role in Metastatic Liver Disease |
spellingShingle |
Magnetic Resonance Imaging Role in Metastatic Liver Disease Santana,Tomás França de Liver/diagnostic imaging Liver Neoplasms/ diagnostic imaging Magnetic Resonance Imaging |
title_short |
Magnetic Resonance Imaging Role in Metastatic Liver Disease |
title_full |
Magnetic Resonance Imaging Role in Metastatic Liver Disease |
title_fullStr |
Magnetic Resonance Imaging Role in Metastatic Liver Disease |
title_full_unstemmed |
Magnetic Resonance Imaging Role in Metastatic Liver Disease |
title_sort |
Magnetic Resonance Imaging Role in Metastatic Liver Disease |
author |
Santana,Tomás França de |
author_facet |
Santana,Tomás França de Laert,José Manso,Nuno Lupi Luersen,Gustavo Felipe Matos,António Pedro |
author_role |
author |
author2 |
Laert,José Manso,Nuno Lupi Luersen,Gustavo Felipe Matos,António Pedro |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Santana,Tomás França de Laert,José Manso,Nuno Lupi Luersen,Gustavo Felipe Matos,António Pedro |
dc.subject.por.fl_str_mv |
Liver/diagnostic imaging Liver Neoplasms/ diagnostic imaging Magnetic Resonance Imaging |
topic |
Liver/diagnostic imaging Liver Neoplasms/ diagnostic imaging Magnetic Resonance Imaging |
description |
Abstract The objective of this study is to provide a comprehensive overview of the utilization of magnetic resonance imaging (MRI) in the identification, characterization, and monitoring of liver metastatic disease, in contrast to alternative imaging modalities, through a bibliographical review and illustrative examples from the author’s clinical practice. The advantages of MRI in this specific context will be explored, emphasizing the utility of hepatospecific contrast agents and the limitations associated with alternative imaging modalities. A comparative analysis of these methods shows that MRI is the most sensitive and specific modality, even more so when using hepatospecific contrast agents, proving to have cost-effectiveness benefits in patient management. It is the authors’ opinion that, provided the technique is available, oncological patient staging where hepatic metastatic disease is a concern should include an abdominal MRI, if possible, with hepatospecific contrast. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-06-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Círculo Médico |
publisher.none.fl_str_mv |
Círculo Médico |
dc.source.none.fl_str_mv |
Gazeta Médica v.11 n.2 2024 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817549563210235904 |